Showing posts with label low dose. Show all posts
Showing posts with label low dose. Show all posts
Friday, April 23, 2010
repost: Advanced ovarian carcinoma: Does a high-dose short-duration schedule of paclitaxel trump prolonged low-dose therapy? - Cancer Network
Ovarian Cancer
Oncology NEWS International. Vol. 19 No. 4
Pages: 1 2
Point / Counterpoint
"Advanced ovarian carcinoma: Does a high-dose short-duration schedule of paclitaxel trump prolonged low-dose therapy?"
Thursday, April 15, 2010
Advanced ovarian carcinoma: Does a high-dose short-duration schedule of paclitaxel trump prolonged low-dose therapy? - Cancer Network
Note: This is a good discussion debating pros/cons (requires registration to view/free) - some excerpts from article:
Point / Counterpoint
Friday, January 22, 2010
Maintenance immunotherapy in recurrent ovarian cancer: Long term follow-up of a phase II study
"Therapy consisted of low-dose subcutaneous IL-2 and oral RA, administered on intermittent schedules for up to 5 years."
Subscribe to:
Posts
(
Atom
)
